Cancer Needs Early Screening Options And Here Is Why
Joshua Smith begins his speech by addressing the severity of cancer in modern-day society. He explains to the audience that statistically 40 percent of all people, are diagnosed with cancer. He emphasizes this with the audience, explaining how this means that two out of five friends, will have cancer in one form or another.
Smith then goes on to the next point about cancer, which is the costly treatment, that has a diminished chance of working, due to patients being forced to wait to see symptoms of said cancer. Smith explains how one-third of all cancer patients throughout the United States, have gone into debt, in an attempt to beat the disease.
How cancer can be treated more efficiently
Smith goes on to explain, that his team and himself are heavily invested in finding new ways, and the development of new technology, which can be implemented to locate, and identify various forms of cancer in their early stages.
Smith explains how this form of technology, will allow for a much more accurate, and faster processing for identifying cancer cells in an individual’s body. Furthermore, Smith explains to the audience, how some forms of cancer, can only be identified when the symptoms show, which is signs of late form cancer, meaning that it may be too late to treat said disease.
It was further explained by Smith how his team had been developing the exact type of technology when things got personal, and his wife was diagnosed with breast cancer. Smith explained how something called Mammograms, essentially served as a screening process for this form of cancer. However, not many people undergo it, due to the price tag.
How to make cancer screening technology more accessible
Smith explained how technology, capable of rapidly categorizing important biomarkers has been developed by his team and himself. This technology is called nano-DLD. He explains how this technology is responsible for automated exosome isolation, where exosomes are tiny molecules, which enable early screening processes for various forms of cancer.
To conclude his speech, Smith declared that he is confident that within the decade, technology such as Nano-DLD will be perfected, and it will be easier to have an optimistic outlook, on individuals who are diagnosed.